Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials
Abstract Determining the optimal antipsychotic target dose in acute phase treatment is of high clinical relevance. The effect of antipsychotics on negative symptoms should be taken into account because patients will often continue on the treatment received in the acute phase. Therefore, we conducted...
Enregistré dans:
Auteurs principaux: | Michel Sabe, Nan Zhao, Alessio Crippa, Stefan Kaiser |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/13453edcfb2c46a08564d4ba189e9f89 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Thought disorder measured as random speech structure classifies negative symptoms and schizophrenia diagnosis 6 months in advance
par: Natália B. Mota, et autres
Publié: (2017) -
Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development
par: Gregory P. Strauss, et autres
Publié: (2021) -
Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment
par: Aleksandr M. Reznik, et autres
Publié: (2020) -
Intermittent theta burst stimulation for negative symptoms of schizophrenia—A double-blind, sham-controlled pilot study
par: Rémy Bation, et autres
Publié: (2021) -
Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
par: Ping Yin, et autres
Publié: (2021)